Canadian Cancer Society logo

Hodgkin lymphoma

You are here: 

Treatment of stage IV Hodgkin lymphoma

The following are treatment options for stage IV Hodgkin lymphoma (HL). The types of treatments given are based on the unique needs of the person with cancer.

A CT scan or positron emission tomography (PET) scan may be used during or after chemotherapy to assess how much more treatment is needed. Depending on the results of the scans, more chemotherapy and radiation or just radiation to areas of bulky disease may be given.

Chemotherapy

Chemotherapy is the primary treatment for stage IV HL. Combination chemotherapy is used to treat HL. The types of combination chemotherapy are:

  • ABVD
    • doxorubicin (Adriamycin)
    • bleomycin (Blenoxane)
    • vinblastine (Velbe)
    • dacarbazine (DTIC)
  • Stanford V
    • mechlorethamine (nitrogen mustard, Mustargen)
    • doxorubicin
    • vinblastine
    • vincristine (Oncovin)
    • bleomycin
    • etoposide (Vepesid)
    • prednisone (Deltasone)
  • BEACOPP
    • bleomycin
    • etoposide
    • doxorubicin
    • cyclophosphamide (Cytoxan, Procytox)
    • vincristine
    • procarbazine hydrochloride (Matulane)
    • prednisone
  • MOPP
    • mechlorethamine
    • vincristine
    • procarbazine hydrochloride
    • prednisone

Radiation therapy

External beam radiation therapy may be offered for stage IV HL. It is given after chemotherapy if the HL is localized in an area of the body and can be included in the radiation field.

Clinical trials

People with HL may be offered the opportunity to participate in clinical trials. For more information, go to clinical trials.

Stories

Tuli Chowdhury I would encourage everyone to volunteer for the Canadian Cancer Society, especially young people.

Read Tuli's story

Funding lifesaving clinical trials

Illustration of science instruments

The Canadian Cancer Society is funding lifesaving clinical trials that give people with cancer access to the newest types of treatment.

Learn more